Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21817954 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
Conditions: Human Papillomavirus Type-16/-18 Infection;   Papillomavirus Vaccines;   Cervical Neoplasia
Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299);   Biological: Menactra TM;   Biological: Boostrix TM

Indicates status has not been verified in more than two years